Lacunary-substituted undecatungstosilicates sensitize methicillin-resistant Staphylococcus aureus to β-lactams

被引:23
作者
Tajima, Y [1 ]
机构
[1] Saga Hosp, Sch Med, Clin Lab, Saga 8498501, Japan
关键词
Staphylococcus aureus; methicillin-resistant; beta-lactam; tungstosilicate; lacunary hole;
D O I
10.1248/bpb.24.1079
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Some Keggin-structural (hetero)polyoxotungstates with a lacunary hole, such as undecatungstosilicate ([SiW11O39](8-), SiW11), greatly sensitize methicillin-resistant Staphylococcus aureus (MRSA) to beta -lactams. In this study, the effects of lacunary-substituted derivatives of SiW11 were tested to determine if the lacunary hole is required for the sensitizing effect. Initially, it was supposed that the hole functioned as a binding site that interacts with some bacterial components. However, most of the lacunary-substituted species had stronger effects than SiW11, indicating that the hole is not essential for the sensitizing effect. Undecatungsto(ferri)ferrosilicate ([SiW11O39Fe](6/5-)) was the most potent compound tested, but undecatungstocobaltosilicate ([SiW11O39CO](6-)) gave better results according to the fractional inhibitory concentration index. Small lipophilic cations enhanced the sensitizing effect, but bulky cations inhibited it. This suggests that a charge interaction between the tungsten compounds and some unknown materials in the culture medium or bacterial cells plays an important role in the sensitizing effect.
引用
收藏
页码:1079 / 1084
页数:6
相关论文
共 26 条
[1]   NEW MODIFIED POLYMERIC ELECTRODES SELECTIVE TO LOCAL-ANESTHETIC COMPOUNDS [J].
BOUKLOUZE, AA ;
ELJAMMAL, A ;
PATRIARCHE, GJ ;
CHRISTIAN, GD .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1991, 9 (05) :393-399
[2]  
CONSTANT R, 1982, J CHEM RES, P50
[3]  
Fukuda N, 1999, BIOL PHARM BULL, V22, P463
[4]  
HAAPALA DK, 1973, BIOMEDICINE, V19, P7
[5]  
Hiramatsu K, 1999, BAILLIERE CLIN INF D, V5, P221
[6]   MOLECULAR EVOLUTION OF MRSA [J].
HIRAMATSU, K .
MICROBIOLOGY AND IMMUNOLOGY, 1995, 39 (08) :531-543
[7]  
INOUYE Y, 1991, CHEM PHARM BULL, V39, P1638
[8]  
JASMIN C, 1973, BIOMEDICINE, V18, P319
[9]  
KEPERT DL, 1973, COMPREHENSIVE INORGA, V4, P607
[10]   HETEROPOLYTUNGSTATES CONTAINING COBALT(II) OR COBALT(III) [J].
KOMURA, A ;
HAYASHI, M ;
IMANAGA, H .
BULLETIN OF THE CHEMICAL SOCIETY OF JAPAN, 1976, 49 (01) :87-91